Table 3 Cox analysis of clinical characteristics and CMR variables for prediction of appropriate ICD therapy
| Â | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| Â | Hazard Ratio (95% CI) | p value | Hazard Ratio (95% CI) | p value |
Clinical and ECG variables | ||||
Pre-ICD revascularization | 0.102 (0.0226-0.461) | 0.003 | 10.8 (2.1-53.6) | 0.001 |
Amiodarone use | 0.21 (0.0274-1.61) | 0.13 | Â | Â |
CMR variables | ||||
LVEF | 0.942 (0.869-1.02) | 0.14 | Â | Â |
Percent scar | 1.08 (1.02-1.16) | 0.014 | Â | Â |
Scar mass | 1.08 (1.04-1.12) | 0.0001 | 3.15 (1.35-7.33) | < 0.001 |
Transmural scar extent | ||||
STAB ≥75% | 1.36 (1–1.83) | 0.048 |  |  |
STLB ≥ 50% | 1.33 (1.04-1.69) | 0.022 |  |  |
SMST total | 1.21 (1–1.45) | 0.045 |  |  |
SMST ≥75% | 1.18 (0.993-1.39) | 0.06 |  |  |